Amgen confirms it will acquire Horizon Therapeutics for $116.50 per share


Amgen confirms it will acquire Horizon Therapeutics for $116.50 per share

#Amgen #confirms #acquire #Horizon #Therapeutics #share

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: